Chief Medical Officer and Head of Research and Development · Evolus, Inc. (EOLS)

Rui Avelar

A named executive officer of Evolus in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,699,084

FY2024: $2,884,613

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Rui Avelar compensation by year

Evolus Summary Compensation Table · all 3 fiscal years held
In US dollars, as Evolus reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$487,750$515,725$545,400
Bonus$0$0$0
Stock awards$1,414,034$1,609,966$645,756
Option awards$691,957$463,571$323,161
Non-equity incentive$320,610$280,500$166,600
Pension and deferred compensation$0$0$0
All other$14,827$14,851$18,167
Total$2,929,178$2,884,613$1,699,084

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evolus, Inc. DEF 14A filed April 29, 2026, accession 0001570562-26-000059, and prior-year filings. Open the filing on EDGAR.

$2.9M
$2.9M
$1.7M
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU52,702$350,468—
RSU26,409$175,620—
RSU26,351$175,234—
RSU23,776$158,110—
RSU17,606$117,080—
RSU13,393$89,063—
Option11,834—$13.15
Option58,230—$5.46
Option189,682—$9.98
Option60,000—$16.19
Option42,834—$11.04
Option45,000—$10.19

Per the Outstanding Equity Awards at Fiscal Year-End table in Evolus, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Evolus’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
David MoatazediPresident and Chief Executive Officer$6,412,214
Tatjana MitchellChief Financial Officer$3,163,272
Sandra BeaverFormer Chief Financial Officer$1,699,898
Rui Avelar · this pageChief Medical Officer and Head of Research and Development$1,699,084
Tomoko Yamagishi-DresslerFormer Chief Marketing Officer$1,588,108

The full Evolus compensation record

free company brief

This page is one person within Evolus's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Evolus's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evolus's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy